Patents by Inventor Thomas M. Farrow

Thomas M. Farrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9078891
    Abstract: The present disclosure describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. The present disclosure also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes. Included in this disclosure is an improved method to isolate and purify 7-hydroxychromones from plant sources.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: July 14, 2015
    Assignee: Unigen, Inc.
    Inventors: Qi Jia, Thomas M. Farrow
  • Publication number: 20130012458
    Abstract: The present disclosure describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. The present disclosure also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes. Included in this disclosure is an improved method to isolate and purify 7-hydroxychromones from plant sources.
    Type: Application
    Filed: February 3, 2012
    Publication date: January 10, 2013
    Applicant: UNIGEN, INC.
    Inventors: Qi Jia, Thomas M. Farrow
  • Patent number: 8110555
    Abstract: The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: February 7, 2012
    Assignee: Unigen, Inc.
    Inventors: Qi Jia, Thomas M. Farrow
  • Publication number: 20100168223
    Abstract: The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes.
    Type: Application
    Filed: March 10, 2010
    Publication date: July 1, 2010
    Applicant: UNIGEN PHARMACEUTICALS, INC.
    Inventors: Qi Jia, Thomas M. Farrow
  • Patent number: 7678772
    Abstract: The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: March 16, 2010
    Assignee: Unigen Pharmaceuticals, Inc.
    Inventors: Qi Jia, Thomas M. Farrow
  • Patent number: 6884783
    Abstract: The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: April 26, 2005
    Assignee: Unigen Pharmaceuticals, Inc.
    Inventors: Qi Jia, Thomas M. Farrow
  • Publication number: 20030207818
    Abstract: The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes.
    Type: Application
    Filed: May 3, 2002
    Publication date: November 6, 2003
    Inventors: Qi Jia, Thomas M. Farrow
  • Patent number: 6451357
    Abstract: The present invention relates generally to a method for the purification of aloesin, a C-glucosylated 5-methylchromone, tyrosinase inhibitor isolated from Aloe.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: September 17, 2002
    Assignee: Unigen Pharmaceuticals, Inc.
    Inventor: Thomas M. Farrow
  • Publication number: 20010000731
    Abstract: The present invention provides a method for the prevention and treatment of chronic venous insufficiency. Specifically, the present invention provides a method for the prevention and treatment of varicose veins, particularly hemorrhoids by application of an effective amount of an isoquinoline alkaloid. Included in this invention is an improved method for isolating and purifying alkaloids, particularly isoquinoline alkaloids from plants.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 3, 2001
    Inventors: Qi Jia, Zhihua Qiu, Ajith Nissanka, Belaid Mahiou, Thomas M. Farrow
  • Patent number: 6210680
    Abstract: The present invention provides a method for the prevention and treatment of chronic venous insufficiency. Specifically, the present invention provides a method for the prevention and treatment of varicose veins, particularly hemorrhoids by application of an effective amount of an isoquinoline alkaloid. Included in this invention is an improved method for isolating and purifying alkaloids, particularly isoquinoline alkaloids from plants.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: April 3, 2001
    Assignee: Univera Pharmaceuticals, Inc.
    Inventors: Qi Jia, Zhihua Qiu, Ajith Nissanka, Belaid Mahiou, Thomas M. Farrow